Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

There are two primary reasons for an addendum. The first is that the document reviewer list
is being updated to include Dr. Richard Cheng and Dr. Roy John, who have critically …

Amyloidosis is a systemic infiltrative disease, in which unstable proteins misfold, form
aggregates and amyloid fibrils which can deposit in various organs: heart, kidneys, liver …

Abstract Background Cardiac Amyloidosis (CA) pertains to the cardiac involvement of a
group of diseases, in which misfolded proteins deposit in tissues and cause progressive …

Objectives This study aimed to compare the diagnostic and prognostic performance of native
T1 mapping (T1), extracellular volume (ECV) mapping, and late gadolinium enhancement …

Systemic amyloidosis encompasses a debilitating, under-diagnosed but increasingly
recognized group of disorders characterized by the extracellular deposition of misfolded …

Aims The study aims to systematically assess the diagnostic performance of cardiac
magnetic resonance (CMR) and nuclear scintigraphy (index tests) for the diagnosis and …

Background This study is a systematic review and meta-analysis of the diagnostic value of
cardiovascular magnetic resonance (CMR) in cardiac amyloidosis (CA). Methods A wide …

Cardiac amyloidosis is a rare, infiltrative cardiomyopathy that presents with thickened
ventricular walls and progressive heart failure. The morphological findings and clinical …

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with
a median survival from diagnosis, if untreated, ranging from< 6 months for light chain …